$3.57 Billion is the total value of Artal Group S.A.'s 134 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 47.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WW | WW INTL INC | $376,088,000 | +50.1% | 14,818,300 | 0.0% | 10.52% | -0.6% | |
| JPM | New | JPMORGAN CHASE & COcall | $282,180,000 | – | 3,000,000 | +100.0% | 7.90% | – |
| BGNE | Buy | BEIGENE LTDsponsored adr | $160,140,000 | +100.1% | 850,000 | +30.8% | 4.48% | +32.5% |
| BNTX | Sell | BIONTECH SEsponsored ads | $133,480,000 | +2.6% | 2,000,000 | -10.2% | 3.74% | -32.1% |
| XLRN | Sell | ACCELERON PHARMA INC | $133,378,000 | -1.1% | 1,400,000 | -6.7% | 3.73% | -34.5% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $133,299,000 | +11.3% | 900,000 | -18.2% | 3.73% | -26.3% |
| LXRX | LEXICON PHARMACEUTICALS INC | $120,181,000 | +2.3% | 60,240,864 | 0.0% | 3.36% | -32.3% | |
| ARGX | Sell | ARGENX SEsponsored adr | $101,354,000 | +62.0% | 450,000 | -5.3% | 2.84% | +7.3% |
| GDS | New | GDS HLDGS LTDsponsored ads | $87,626,000 | – | 1,100,000 | +100.0% | 2.45% | – |
| SDGR | SCHRODINGER INC | $82,179,000 | +112.4% | 897,445 | 0.0% | 2.30% | +40.6% | |
| BABA | Sell | ALIBABA GROUP HLDG LTDsponsored ads | $80,348,000 | +3.3% | 372,500 | -6.9% | 2.25% | -31.6% |
| BDTX | Sell | BLACK DIAMOND THERAPEUTICS I | $65,201,000 | +54.0% | 1,546,517 | -8.8% | 1.82% | +2.0% |
| FATE | Sell | FATE THERAPEUTICS INC | $61,758,000 | +32.4% | 1,800,000 | -14.3% | 1.73% | -12.3% |
| GBIO | New | GENERATION BIO CO | $59,098,000 | – | 2,814,191 | +100.0% | 1.65% | – |
| ALXN | New | ALEXION PHARMACEUTICALS INCcall | $56,120,000 | – | 500,000 | +100.0% | 1.57% | – |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $52,780,000 | +14.2% | 3,500,000 | -30.0% | 1.48% | -24.3% |
| C | New | CITIGROUP INCcall | $51,100,000 | – | 1,000,000 | +100.0% | 1.43% | – |
| SRRK | Sell | SCHOLAR ROCK HLDG CORP | $45,963,000 | +49.1% | 2,524,040 | -0.9% | 1.29% | -1.3% |
| MORF | Sell | MORPHIC HLDG INC | $45,151,000 | +69.1% | 1,669,186 | -8.2% | 1.26% | +11.9% |
| QURE | Sell | UNIQURE NV | $45,060,000 | -17.4% | 1,000,000 | -13.0% | 1.26% | -45.3% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $42,900,000 | +83.4% | 550,000 | +37.5% | 1.20% | +21.3% |
| GS | New | GOLDMAN SACHS GROUP INCcall | $39,524,000 | – | 200,000 | +100.0% | 1.11% | – |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $38,818,000 | +17.9% | 650,000 | -18.8% | 1.09% | -22.0% |
| ATRA | ATARA BIOTHERAPEUTICS INC | $36,425,000 | +71.2% | 2,500,000 | 0.0% | 1.02% | +13.3% | |
| RPRX | New | ROYALTY PHARMA PLC | $36,413,000 | – | 750,000 | +100.0% | 1.02% | – |
| DAL | New | DELTA AIR LINES INC DELcall | $35,063,000 | – | 1,250,000 | +100.0% | 0.98% | – |
| PYPL | Sell | PAYPAL HLDGS INC | $34,846,000 | -17.3% | 200,000 | -54.5% | 0.98% | -45.2% |
| GOSS | Buy | GOSSAMER BIO INC | $34,567,000 | +88.3% | 2,658,968 | +47.0% | 0.97% | +24.6% |
| TGTX | Buy | TG THERAPEUTICS INC | $34,090,000 | +246.4% | 1,750,000 | +75.0% | 0.95% | +129.3% |
| AVTR | Sell | AVANTOR INC | $34,000,000 | -39.5% | 2,000,000 | -55.6% | 0.95% | -60.0% |
| MRNA | Sell | MODERNA INC | $32,105,000 | -64.3% | 500,000 | -83.3% | 0.90% | -76.3% |
| XLI | Sell | SELECT SECTOR SPDR TRcall | $30,915,000 | -12.7% | 450,000 | -25.0% | 0.86% | -42.2% |
| EPZM | Sell | EPIZYME INC | $30,113,000 | -15.6% | 1,875,000 | -18.5% | 0.84% | -44.1% |
| TBIO | Buy | TRANSLATE BIO INC | $28,672,000 | +379.3% | 1,600,000 | +166.7% | 0.80% | +217.0% |
| Z | Sell | ZILLOW GROUP INCcl c cap stk | $27,826,000 | -14.2% | 483,000 | -46.3% | 0.78% | -43.1% |
| ABBV | New | ABBVIE INCcall | $24,545,000 | – | 250,000 | +100.0% | 0.69% | – |
| NG | New | NOVAGOLD RES INC | $23,868,000 | – | 2,600,000 | +100.0% | 0.67% | – |
| BAC | Sell | BK OF AMERICA CORPcall | $23,750,000 | -44.1% | 1,000,000 | -50.0% | 0.66% | -62.9% |
| RUBY | Sell | RUBIUS THERAPEUTICS INC | $23,037,000 | +33.3% | 3,852,341 | -0.8% | 0.64% | -11.6% |
| TPTX | Buy | TURNING POINT THERAPEUTICS I | $22,607,000 | +68.7% | 350,000 | +16.7% | 0.63% | +11.8% |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $20,108,000 | +41.7% | 376,000 | -6.0% | 0.56% | -6.2% |
| AAL | New | AMERICAN AIRLS GROUP INC | $19,605,000 | – | 1,500,000 | +100.0% | 0.55% | – |
| BBIO | Buy | BRIDGEBIO PHARMA INC | $19,566,000 | +22.7% | 600,000 | +9.1% | 0.55% | -18.8% |
| ADVM | Buy | ADVERUM BIOTECHNOLOGIES INC | $18,792,000 | +220.6% | 900,000 | +50.0% | 0.53% | +112.1% |
| MRSN | New | MERSANA THERAPEUTICS INC | $18,720,000 | – | 800,000 | +100.0% | 0.52% | – |
| REPL | Buy | REPLIMUNE GROUP INC | $18,638,000 | +211.6% | 750,000 | +25.0% | 0.52% | +105.9% |
| RPTX | New | REPARE THERAPEUTICS INC | $18,612,000 | – | 600,000 | +100.0% | 0.52% | – |
| TECH | New | BIO-TECHNE CORP | $17,165,000 | – | 65,000 | +100.0% | 0.48% | – |
| FGEN | Sell | FIBROGEN INC | $16,212,000 | -22.2% | 400,000 | -33.3% | 0.45% | -48.5% |
| ARAV | Sell | ARAVIVE INC | $16,067,000 | +92.4% | 1,380,306 | -4.8% | 0.45% | +27.5% |
| EPZM | Buy | EPIZYME INCcall | $16,060,000 | +314.1% | 1,000,000 | +300.0% | 0.45% | +173.8% |
| TCOM | Buy | TRIP COM GROUP LTDads | $15,552,000 | +42.6% | 600,000 | +29.0% | 0.44% | -5.6% |
| FOLD | AMICUS THERAPEUTICS INCcall | $15,080,000 | +63.2% | 1,000,000 | 0.0% | 0.42% | +8.2% | |
| HARP | Sell | HARPOON THERAPEUTICS INC | $14,940,000 | +7.5% | 900,000 | -25.0% | 0.42% | -28.8% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INCcall | $14,811,000 | – | 100,000 | +100.0% | 0.41% | – |
| AUPH | Buy | AURINIA PHARMACEUTICALS INC | $14,625,000 | +34.4% | 900,000 | +20.0% | 0.41% | -11.1% |
| VNET | Sell | 21VIANET GROUP INCsponsored ads | $13,910,000 | +0.4% | 583,000 | -41.7% | 0.39% | -33.6% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $13,725,000 | -38.9% | 500,000 | -33.3% | 0.38% | -59.5% |
| ALBO | Sell | ALBIREO PHARMA INC | $13,255,000 | +37.7% | 500,360 | -14.9% | 0.37% | -8.8% |
| YMAB | Sell | Y-MABS THERAPEUTICS INC | $12,961,000 | +24.1% | 300,030 | -25.0% | 0.36% | -17.7% |
| GM | New | GENERAL MTRS COcall | $12,650,000 | – | 500,000 | +100.0% | 0.35% | – |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $12,600,000 | +33.3% | 300,000 | -14.3% | 0.35% | -11.5% |
| PRNB | Sell | PRINCIPIA BIOPHARMA INC | $11,958,000 | -19.4% | 200,000 | -20.0% | 0.34% | -46.6% |
| STNE | Sell | STONECO LTD | $11,240,000 | +29.1% | 290,000 | -27.5% | 0.31% | -14.7% |
| AGEN | Buy | AGENUS INC | $11,201,000 | +82.9% | 2,850,000 | +14.0% | 0.31% | +20.8% |
| CYCN | Sell | CYCLERION THERAPEUTICS INC | $10,883,000 | +120.6% | 1,841,584 | -1.1% | 0.30% | +46.2% |
| DNLI | Sell | DENALI THERAPEUTICS INC | $10,881,000 | +24.3% | 450,000 | -10.0% | 0.30% | -17.8% |
| AGLE | Buy | AEGLEA BIOTHERAPEUTICS INC | $10,175,000 | +445.9% | 1,100,000 | +175.0% | 0.28% | +260.8% |
| BNTX | New | BIONTECH SEcall | $10,011,000 | – | 150,000 | +100.0% | 0.28% | – |
| SAGE | Sell | SAGE THERAPEUTICS INC | $9,730,000 | -3.2% | 234,000 | -33.1% | 0.27% | -36.0% |
| IMAB | Sell | I MABsponsored ads | $9,697,000 | +113.1% | 324,000 | -7.4% | 0.27% | +41.1% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $9,614,000 | -14.6% | 65,000 | -35.0% | 0.27% | -43.5% |
| KURA | Buy | KURA ONCOLOGY INC | $9,421,000 | +136.7% | 578,000 | +44.5% | 0.26% | +57.1% |
| ADPT | Sell | ADAPTIVE BIOTECHNOLOGIES COR | $9,095,000 | +63.7% | 188,000 | -6.0% | 0.25% | +8.1% |
| AXDX | Sell | ACCELERATE DIAGNOSTICS INC | $8,891,000 | +77.9% | 586,500 | -2.2% | 0.25% | +18.0% |
| RGNX | Sell | REGENXBIO INC | $8,618,000 | +6.5% | 234,000 | -6.4% | 0.24% | -29.5% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $8,284,000 | +91.6% | 200,000 | +100.0% | 0.23% | +26.8% |
| SELB | Sell | SELECTA BIOSCIENCES INC | $8,236,000 | +0.1% | 2,900,000 | -15.0% | 0.23% | -33.9% |
| IMMU | New | IMMUNOMEDICS INC | $8,181,000 | – | 230,838 | +100.0% | 0.23% | – |
| TCDA | Sell | TRICIDA INC | $7,832,000 | -1.1% | 285,000 | -20.8% | 0.22% | -34.6% |
| AKBA | Buy | AKEBIA THERAPEUTICS INC | $7,795,000 | +141.9% | 574,000 | +35.1% | 0.22% | +60.3% |
| MLCO | MELCO RESORTS AND ENTMNT LTDcall | $7,760,000 | +25.2% | 500,000 | 0.0% | 0.22% | -17.2% | |
| Sell | TRILLIUM THERAPEUTICS INC | $7,710,000 | +90.8% | 953,000 | -4.7% | 0.22% | +26.3% | |
| PRQR | Sell | PROQR THRAPEUTICS N V | $7,656,000 | +7.3% | 1,259,177 | -3.1% | 0.21% | -29.1% |
| BRKR | New | BRUKER CORP | $7,505,000 | – | 184,500 | +100.0% | 0.21% | – |
| SPRO | Sell | SPERO THERAPEUTICS INC | $7,374,000 | +58.4% | 545,040 | -5.4% | 0.21% | +4.6% |
| IMUX | Sell | IMMUNIC INC | $7,272,000 | +90.8% | 600,000 | -4.8% | 0.20% | +26.1% |
| HOOK | Sell | HOOKIPA PHARMA INC | $6,968,000 | +6.1% | 599,616 | -24.7% | 0.20% | -29.9% |
| STOK | Buy | STOKE THERAPEUTICS INC | $6,792,000 | +18.6% | 285,000 | +14.0% | 0.19% | -21.5% |
| ACIU | Sell | AC IMMUNE SA | $6,626,000 | -4.1% | 984,550 | -1.5% | 0.18% | -36.6% |
| APTX | Sell | APTINYX INC | $6,593,000 | +83.1% | 1,581,090 | -5.1% | 0.18% | +21.1% |
| AAL | AMERICAN AIRLS GROUP INCcall | $6,535,000 | +7.2% | 500,000 | 0.0% | 0.18% | -29.1% | |
| PASG | Sell | PASSAGE BIO INC | $6,395,000 | +62.4% | 234,000 | -6.4% | 0.18% | +7.8% |
| AUTL | Sell | AUTOLUS THERAPEUTICS PLCsponsored ads | $6,412,000 | +114.1% | 400,000 | -20.0% | 0.18% | +40.9% |
| ADCT | New | ADC THERAPEUTICS SA | $6,366,000 | – | 136,000 | +100.0% | 0.18% | – |
| LPTX | Buy | LEAP THERAPEUTICS INC | $6,216,000 | +1473.7% | 2,974,000 | +1089.6% | 0.17% | +923.5% |
| MRUS | Sell | MERUS N V | $6,179,000 | +2.1% | 384,000 | -23.2% | 0.17% | -32.4% |
| HTHT | New | HUAZHU GROUP LTDsponsored ads | $6,134,000 | – | 175,000 | +100.0% | 0.17% | – |
| TSM | New | TAIWAN SEMICONDUCTOR MFG LTDcall | $5,677,000 | – | 100,000 | +100.0% | 0.16% | – |
| NKTR | New | NEKTAR THERAPEUTICS | $5,535,000 | – | 239,000 | +100.0% | 0.16% | – |
| PRVL | Buy | PREVAIL THERAPEUTICS INC | $5,513,000 | +126.1% | 370,000 | +85.0% | 0.15% | +49.5% |
| TCRR | Sell | TCR2 THERAPEUTICS INC | $5,376,000 | +73.6% | 350,000 | -12.5% | 0.15% | +14.5% |
| SLDB | SOLID BIOSCIENCES INC | $5,274,000 | +22.6% | 1,800,000 | 0.0% | 0.15% | -18.7% | |
| SYRS | Sell | SYROS PHARMACEUTICALS INC | $5,223,000 | +74.0% | 490,000 | -3.2% | 0.15% | +15.0% |
| ORIC | New | ORIC PHARMACEUTICALS INC | $5,060,000 | – | 150,000 | +100.0% | 0.14% | – |
| NTLA | New | INTELLIA THERAPEUTICS INC | $5,024,000 | – | 239,000 | +100.0% | 0.14% | – |
| AXLA | Buy | AXCELLA HEALTH INC | $4,977,000 | +142.5% | 900,000 | +50.0% | 0.14% | +59.8% |
| RNA | New | AVIDITY BIOSCIENCES INC | $4,946,000 | – | 175,000 | +100.0% | 0.14% | – |
| ALEC | Sell | ALECTOR INC | $4,888,000 | -19.0% | 200,000 | -20.0% | 0.14% | -46.3% |
| ZNTL | New | ZENTALIS PHARMACEUTICALS INC | $4,418,000 | – | 92,000 | +100.0% | 0.12% | – |
| YI | 111 INCads | $4,128,000 | -3.9% | 650,000 | 0.0% | 0.12% | -36.8% | |
| PRTA | Buy | PROTHENA CORP PLC | $3,870,000 | +20.6% | 370,000 | +23.3% | 0.11% | -20.6% |
| KLDO | KALEIDO BIOSCIENCES INC | $3,719,000 | +20.8% | 500,500 | 0.0% | 0.10% | -20.0% | |
| MGTA | New | MAGENTA THERAPEUTICS INC | $3,380,000 | – | 450,000 | +100.0% | 0.10% | – |
| IDYA | New | IDEAYA BIOSCIENCES INC | $3,401,000 | – | 239,304 | +100.0% | 0.10% | – |
| CLVS | CLOVIS ONCOLOGY INCcall | $3,375,000 | +6.1% | 500,000 | 0.0% | 0.09% | -29.9% | |
| EVLO | New | EVELO BIOSCIENCES INC | $3,267,000 | – | 666,666 | +100.0% | 0.09% | – |
| MEIP | New | MEI PHARMA INC | $2,949,000 | – | 714,000 | +100.0% | 0.08% | – |
| NERV | Sell | MINERVA NEUROSCIENCES INC | $2,888,000 | -52.0% | 800,000 | -20.0% | 0.08% | -68.1% |
| CYRX | New | CRYOPORT INC | $2,692,000 | – | 89,000 | +100.0% | 0.08% | – |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $2,472,000 | – | 140,000 | +100.0% | 0.07% | – |
| ORTX | Sell | ORCHARD THERAPEUTICS PLCads | $2,220,000 | -26.3% | 370,000 | -7.5% | 0.06% | -51.2% |
| ADRO | Sell | ADURO BIOTECH INC | $2,195,000 | -19.9% | 950,000 | -5.0% | 0.06% | -47.4% |
| TORC | New | RESTORBIO INC | $2,049,000 | – | 953,000 | +100.0% | 0.06% | – |
| XLE | New | SELECT SECTOR SPDR TRcall | $1,893,000 | – | 50,000 | +100.0% | 0.05% | – |
| CRIS | Sell | CURIS INC | $1,789,000 | +69.4% | 1,478,662 | -1.4% | 0.05% | +11.1% |
| VXRT | New | VAXART INC | $1,770,000 | – | 200,000 | +100.0% | 0.05% | – |
| CTMX | New | CYTOMX THERAPEUTICS INC | $1,566,000 | – | 188,000 | +100.0% | 0.04% | – |
| BLU | New | BELLUS HEALTH INC NEW | $1,479,000 | – | 143,763 | +100.0% | 0.04% | – |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $1,141,000 | +2.3% | 110,532 | 0.0% | 0.03% | -31.9% | |
| CDTX | New | CIDARA THERAPEUTICS INC | $873,000 | – | 236,500 | +100.0% | 0.02% | – |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $619,000 | +13.4% | 338,000 | -3.4% | 0.02% | -26.1% |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INC | $0 | – | -200,000 | -100.0% | -0.06% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -100,000 | -100.0% | -0.19% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -1,000,000 | -100.0% | -0.27% | – |
| UBER | Exit | UBER TECHNOLOGIES INC | $0 | – | -400,000 | -100.0% | -0.47% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORPcall | $0 | – | -200,000 | -100.0% | -0.49% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INCcall | $0 | – | -200,000 | -100.0% | -0.71% | – |
| ARWR | Exit | ARROWHEAD PHARMACEUTICALS IN | $0 | – | -600,000 | -100.0% | -0.73% | – |
| MA | Exit | MASTERCARD INCcall | $0 | – | -100,000 | -100.0% | -1.02% | – |
| XBI | Exit | SPDR SER TRcall | $0 | – | -500,000 | -100.0% | -1.64% | – |
| BABA | Exit | ALIBABA GROUP HLDG LTDcall | $0 | – | -400,000 | -100.0% | -3.29% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.